Cosmin A. Tegla

Hematology
550 1st Ave
New York, NY 10016

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C.

Diffuse large B-cell lymphoma with cutaneous involvement in a patient with xeroderma pigmentosum type C.

Journal: JAAD case reports
Published: June 17, 2024

Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults.

Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults.

Journal: Clinical hematology international
Published: November 18, 2019

miR-29 Sustains B Cell Survival and Controls Terminal Differentiation via Regulation of PI3K Signaling.

miR-29 Sustains B Cell Survival and Controls Terminal Differentiation via Regulation of PI3K Signaling.

Journal: Cell reports
Published: November 04, 2019

STAT3 Dysregulation in Mature T and NK Cell Lymphomas.

STAT3 Dysregulation in Mature T and NK Cell Lymphomas.

Journal: Cancers
Published: October 25, 2019

RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitis.

RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitis.

Journal: Immunologic research
Published: July 15, 2018

SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis.

SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis.

Journal: Experimental and molecular pathology
Published: January 17, 2017

RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis.

RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 22, 2016

RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.

RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.

Journal: Experimental and molecular pathology
Published: September 08, 2015

RGC-32 is a novel regulator of the T-lymphocyte cell cycle.

RGC-32 is a novel regulator of the T-lymphocyte cell cycle.

Journal: Experimental and molecular pathology
Published: March 07, 2015

Role of SIRT1 in autoimmune demyelination and neurodegeneration.

Role of SIRT1 in autoimmune demyelination and neurodegeneration.

Journal: Immunologic research
Published: October 05, 2014

SIRT1 is decreased during relapses in patients with multiple sclerosis.

SIRT1 is decreased during relapses in patients with multiple sclerosis.

Journal: Experimental and molecular pathology
Published: December 19, 2013

Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.

Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.

Journal: Immunologic research
Published: December 19, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026